Antibody-drug conjugates

Nat Rev Drug Discov. 2013 Apr;12(4):259-60. doi: 10.1038/nrd3980.
No abstract available

Publication types

  • News

MeSH terms

  • Ado-Trastuzumab Emtansine
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Brentuximab Vedotin
  • Drug Design*
  • Drug Industry / trends
  • Humans
  • Immunoconjugates / administration & dosage
  • Immunoconjugates / therapeutic use*
  • Maytansine / administration & dosage
  • Maytansine / analogs & derivatives
  • Maytansine / therapeutic use
  • Molecular Targeted Therapy
  • Technology, Pharmaceutical / methods
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoconjugates
  • Maytansine
  • Brentuximab Vedotin
  • Trastuzumab
  • Ado-Trastuzumab Emtansine